Melanotan I (Afamelanotide) Dosage and Protocols
Melanotan I (Afamelanotide) dosage protocols reported in published research, plus reconstitution and storage.
Approved Implant vs. Research Vial
The FDA-approved Scenesse product is a 16mg subcutaneous implant administered roughly monthly by a healthcare provider. Research-vendor vials are commonly reconstituted and dosed in smaller increments (research-typical protocols vary considerably) — this does not replicate the approved implant's controlled, sustained-release delivery.
Reported protocol doses
Reconstitution
A 10mg vial with 2mL of bacteriostatic water is the pairing reported most often. Research-vendor convention: 10mg vial reconstituted with 2mL bacteriostatic water. The FDA-approved Scenesse product is a subcutaneous implant, not an injectable vial.
Work out your own concentration with the reconstitution calculator.
Doses shown are those reported in published research, not a recommendation.
References
- Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo · Lim HW, et al. · 2015